NCT07196436 Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
| NCT ID | NCT07196436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas at Arlington |
| Condition | Asthma Control |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-10-10 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-10-10 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary goal of this study is to investigate the comparative long-term (i.e., 1-year) effectiveness of energy recovery ventilators (ERVs) and portable air cleaners (PACs) in reducing indoor air pollutants and mold levels and improving asthma-related health outcomes in inner-city children and adults with asthma in low-income households in the Dallas-Fort Worth (DFW) metropolitan area, TX. Secondary goals include: (1) examining associations among asthma outcomes, exposure to indoor air pollutants and mold, and housing-related factors, (2) conducting a cost-benefit analysis of ERV and PAC interventions for improving IAQ, mold control, and health outcomes, and (3) evaluating the utility of cost-effective methods and protocols for measuring IAQ and mold for indoor air pollution epidemiology studies and for providing practical information to patients and their physicians. Using a double-blind, placebo-controlled randomized controlled trial, 80 households will be assigned to receive active or placebo versions of ERVs or PACs. Environmental exposures and housing conditions will be monitored alongside comprehensive health assessments, including lung function tests and validated surveys on asthma control, quality of life, stress, and sleep quality.
Eligibility Criteria
Inclusion Criteria: * Individuals with physician-diagnosed asthma, including both adults and children aged 5-17 * Homeowners living in the DFW metropolitan area, TX Exclusion Criteria: * Participants living in homes with any smokers
Contact & Investigator
Insung Kang, Ph.D.
PRINCIPAL INVESTIGATOR
The University of Texas at Arlington
Frequently Asked Questions
Who can join the NCT07196436 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Asthma Control. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07196436 currently recruiting?
Yes, NCT07196436 is actively recruiting participants. Contact the research team at insung.kang@uta.edu for enrollment information.
Where is the NCT07196436 trial being conducted?
This trial is being conducted at Arlington, United States, Plano, United States.
Who is sponsoring the NCT07196436 clinical trial?
NCT07196436 is sponsored by The University of Texas at Arlington. The principal investigator is Insung Kang, Ph.D. at The University of Texas at Arlington. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.